ATC level 3
L02AHormonal cancer treatments, subgroup L02A
- Molecules
- 7
- Subgroups
- 2
ATC L02A (Hormonal cancer treatments, subgroup L02A) is a level 3 group in the anatomical therapeutic chemical classification. The catalogue lists 7 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
Molecules
Molecules with an ATC code under L02A.
- GoserelinGonadotropin Releasing Hormone Receptor Agonist2 presentations1 brandL02AE03
- HistrelinOrphanGonadotropin Releasing Hormone Receptor Agonist1 presentation1 brandL02AE05
- LeuprolideOrphanGonadotropin Releasing Hormone Receptor Agonist23 presentations9 brandsL02AE02
- Leuprorelin1 brandL02AE02
- MedroxyprogesteroneProgestin10 presentations3 brandsG03AC06
- MegestrolOrphanProgestin4 presentationsL02AB01
- TriptorelinOrphan4 presentations2 brandsL02AE04
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.